Hikma Pharmaceutical | HIK - Sales Revenues

Stock Price
1,436.00
Daily Change
-4.00 -0.28%
Monthly
4.25%
Yearly
-30.56%
Q2 Forecast
1,414.37

Hikma Pharmaceutical reported $1.69B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Almirall EUR 547.63M 12.83M Dec/2025
argenx SE USD 1.12B 0 Mar/2026
AstraZeneca USD 15.29B 213M Mar/2026
Autolus Therapeutics Ltd USD 26.22M 1.93M Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Fresenius EUR 5.74B 140M Mar/2026
Genmab DKK 1.06B 36M Dec/2025
GlaxoSmithKline GBP 7.63B 991M Mar/2026
GRIFOLS EUR 1.7B 280M Mar/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Lakefront Biotherapeutics EUR 6.5M 894.32M Mar/2026
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.13B 120M Mar/2026
Orion EUR 417.7M 277.6M Mar/2026
Recordati EUR 713.42M 51.42M Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
UCB EUR 4.25B 764M Dec/2025